ArticleJournal of cancer survivorship : research and practice2026
Visualizing Health Related Quality of Life (HRQoL): understanding comprehension of HRQoL graphs in the allogeneic hematopoietic cell transplant setting.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeAs survival improves for allogeneic hematopoietic cell transplant (alloHCT) recipients, discussions about health-related quality of life (HRQoL) become increasingly important. Previous research has suggested best practices for sharing HRQoL data graphically, but not in the alloHCT setting. This study aimed to evaluate comprehension of graphical displays of HRQoL among stakeholders in alloHCT and to make recommendations for displaying clinically concerning HRQoL.
methodsAn online survey assessed comprehension of HRQoL graphs among alloHCT recipients, their caregivers, and care team members. Participants were randomized to see 8 of 32 unique graphs, which varied in how clinically concerning scores were indicated (primary comparison), HRQoL domain, and score pattern. Four comprehension questions followed each graph. Open-ended questions queried for graph design preferences. Qualitative interviews with care team members assessed priorities for using HRQoL graphs in clinical settings.
results190 patients, 38 caregivers, and 18 care team members completed surveys. Median comprehension score was 31/32 across all groups, with wider ranges among patients (5-32) and caregivers (6-32) than care team members (22-32). Threshold line graphs were more likely to be interpreted correctly by adult patients than red circle graphs (OR, 6.07; 95% CI 2.34, 15.8. 78% of participants preferred the threshold design. Qualitative interviews with seven care team members revealed four implementation-related themes: a need for clear guidance, improved communication, integration with existing systems, and impact to patients.
conclusionsComprehension of HRQoL graphs was high among all alloHCT stakeholder groups, providing confidence for their use in clinical settings. IMPLICATIONS FOR CANCER SURVIVORS: The findings of this study suggest that HRQoL graphs are comprehensible among key alloHCT stakeholder groups, regardless of health literacy level. Results also show that threshold lines are a preferred and universally understood method for distinguishing clinically concerning HRQoL and that care team members are motivated to use HRQoL graphs with patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.